Wanbury Limited (WANBURY.NS)
INR 248.41
(2.6%)
INR 248.41
(2.6%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.43 Billion INR | 13.04% |
| 2022 | 3.03 Billion INR | -13.81% |
| 2021 | 3.52 Billion INR | 21.91% |
| 2020 | 2.89 Billion INR | 3.76% |
| 2019 | 2.78 Billion INR | -2.57% |
| 2018 | 2.86 Billion INR | 5.22% |
| 2017 | 2.71 Billion INR | -34.97% |
| 2016 | 4.18 Billion INR | 9.01% |
| 2015 | 3.83 Billion INR | -5.47% |
| 2014 | 4.05 Billion INR | 0.0% |
| 2012 | 7.72 Billion INR | -4.7% |
| 2011 | 8.1 Billion INR | 0.48% |
| 2010 | 8.07 Billion INR | 0.09% |
| 2009 | 8.06 Billion INR | -3.27% |
| 2008 | 8.33 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 3.43 Billion INR | 0.0% |
| 2023 FY | 3.43 Billion INR | 13.04% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 3.46 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 3.03 Billion INR | -13.81% |
| 2022 Q4 | 3.03 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 3.43 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 3.59 Billion INR | 0.0% |
| 2021 FY | 3.52 Billion INR | 21.91% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 3.52 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 2.89 Billion INR | 0.0% |
| 2020 FY | 2.89 Billion INR | 3.76% |
| 2020 Q2 | 2.89 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 2.78 Billion INR | -2.57% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 2.78 Billion INR | 0.0% |
| 2019 Q2 | 2.84 Billion INR | 0.0% |
| 2018 FY | 2.86 Billion INR | 5.22% |
| 2018 Q4 | 2.86 Billion INR | 0.0% |
| 2017 FY | 2.71 Billion INR | -34.97% |
| 2016 FY | 4.18 Billion INR | 9.01% |
| 2015 FY | 3.83 Billion INR | -5.47% |
| 2014 FY | 4.05 Billion INR | 0.0% |
| 2012 FY | 7.72 Billion INR | -4.7% |
| 2011 FY | 8.1 Billion INR | 0.48% |
| 2010 FY | 8.07 Billion INR | 0.09% |
| 2009 FY | 8.06 Billion INR | -3.27% |
| 2008 Q4 | 8.33 Billion INR | 0.0% |
| 2008 FY | 8.33 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aarti Drugs Limited | 24.32 Billion INR | 85.878% |
| Albert David Limited | 4.97 Billion INR | 31.024% |
| Alembic Limited | 23.28 Billion INR | 85.25% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -629.553% |
| Hester Biosciences Limited | 6.62 Billion INR | 48.14% |
| Hikal Limited | 24.87 Billion INR | 86.189% |
| Ind-Swift Limited | 6.54 Billion INR | 47.516% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -43.085% |
| Unichem Laboratories Limited | 31.69 Billion INR | 89.162% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 94.671% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -132.59% |
| Bajaj HealthCare Limited | 7.65 Billion INR | 55.106% |
| Brooks Laboratories Limited | 904.45 Million INR | -279.78% |
| Eris Lifesciences Limited | 70.48 Billion INR | 95.127% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | 85.362% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -58.235% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 86.697% |
| Alkem Laboratories Limited | 155.74 Billion INR | 97.795% |
| FDC Limited | 24.68 Billion INR | 86.083% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 87.949% |
| Gufic Biosciences Limited | 10.92 Billion INR | 68.56% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | 70.518% |
| Innova Captab Limited | 13.2 Billion INR | 73.995% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 84.696% |
| Ipca Laboratories Limited | 111.01 Billion INR | 96.906% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 97.026% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | 50.95% |
| Lupin Limited | 239.97 Billion INR | 98.569% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -3.02% |
| Medico Remedies Limited | 961.95 Million INR | -257.079% |
| Morepen Laboratories Limited | 12.93 Billion INR | 73.439% |
| Nectar Lifesciences Limited | 21.91 Billion INR | 84.323% |
| Orchid Pharma Limited | 15.53 Billion INR | 77.894% |
| Procter & Gamble Health Limited | 7.94 Billion INR | 56.759% |
| RPG Life Sciences Limited | 5.12 Billion INR | 33.025% |
| Sigachi Industries Limited | 6.94 Billion INR | 50.516% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.598% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | 84.761% |
| Themis Medicare Limited | 5.66 Billion INR | 39.357% |
| Vaishali Pharma Limited | 799.55 Million INR | -329.604% |
| Venus Remedies Limited | 6.26 Billion INR | 45.202% |
| Windlas Biotech Limited | 6.26 Billion INR | 45.147% |
| ZIM Laboratories Limited | 4.46 Billion INR | 23.125% |
| Sakar Healthcare Limited | 3.88 Billion INR | 11.621% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 99.238% |
| Divi's Laboratories Limited | 154.7 Billion INR | 97.78% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | 68.137% |
| Mankind Pharma Limited | 119.63 Billion INR | 97.129% |
| Sequent Scientific Limited | 15.4 Billion INR | 77.701% |
| Laurus Labs Limited | 83.87 Billion INR | 95.904% |
| Neuland Laboratories Limited | 18.32 Billion INR | 81.256% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 91.4% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 97.608% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 98.827% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | 6.372% |
| Wockhardt Limited | 76.49 Billion INR | 95.509% |
| Bal Pharma Limited | 3.2 Billion INR | -7.211% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 99.114% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | 71.703% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -238.047% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | 87.266% |
| Shilpa Medicare Limited | 30.93 Billion INR | 88.895% |
| Valiant Laboratories Limited | 3.42 Billion INR | -0.235% |
| Ajanta Pharma Limited | 46.38 Billion INR | 92.595% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -12.624% |
| Granules India Limited | 55.2 Billion INR | 93.778% |
| Medicamen Biotech Limited | 2.94 Billion INR | -16.627% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | 15.116% |
| Piramal Enterprises Limited | 826.05 Billion INR | 99.584% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 97.719% |
| NATCO Pharma Limited | 69.06 Billion INR | 95.026% |
| Suven Life Sciences Limited | 2.84 Billion INR | -20.565% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -92.784% |
| Strides Pharma Science Limited | 58.39 Billion INR | 94.118% |
| Indoco Remedies Limited | 21.44 Billion INR | 83.984% |
| Alpa Laboratories Limited | 1.82 Billion INR | -88.09% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -127.677% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 33.307% |